By Donald Zuhn --
A study released earlier this year by Ocean Tomo highlights the emergence of intellectual capital and how the U.S. has transitioned to an innovation-based economy over the past 35 years. The company's Intangible Asset Market Value study indicated that in 2010, 80% of company value (for the S&P 500) was comprised of intangible assets, and that physical and financial accountable assets constituted only 20% of company value. The study also showed that a significant portion of the intangible value was represented by patented technology. The relative value of intangible and tangible assets has completely flipped since 1975, when 83% of corporate value was due to tangible assets and only 17% was derived from intangible assets.
In a separate report -- the Ocean Tomo Patent Quality Inventor study -- the IP financial products company focused on the importance of inventors on corporate value by identifying the top inventors within four technology sectors: biotech, industrials, semiconductors, and wireless. Inventor ranking was based on the average patent IPQ® score for each inventor's 2010 issued and active U.S. patents within noted U.S. Patent Office Classifications. In the biotech sector, the report awarded the top spot to Dr. Travis Mickle, who has received 16 patents falling within the 435 (Chemistry: Molecular Biology and Microbiology) and 436 (Chemistry: Analytical and Immunological Testing) classes that have an average IPQ score of 185.1 (where the median score is 100). The report noted that this average placed Dr. Mickle's patents, which are directed to abuse-resistant amphetamine prodrugs, in the top 1% of all active U.S. utility patents. The 16 patents are: 7,723,305; 7,718,619; 7,713,936; 7,700,561; 7,687,467; 7,687,466; 7,678,771; 7,678,770; 7,674,774; 7,671,031; 7,671,030; 7,662,788; 7,662,787; 7,659,254; 7,659,253; 7,655,630.